By Justin Petrone

Affymetrix this week began shipping its Axiom Exome Genotyping Arrays with the hope that the new chip's content and custom design options can capture what appears to be strong demand in the marketplace for such products.

"We have exceeded our content expectations on the product; it is now available, in inventory, and we are taking orders," Andy Last, executive vice president of Affy's genetic analysis and clinical applications business unit, told BioArray News this week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.